Compare ADMA Biologics Inc (ADMA) vs Impinj Inc (PI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs Impinj Inc — how do they compare? ADMA Biologics Inc trades at $9.88 (market cap $2.22B), while Impinj Inc trades at $177.46 (market cap $5.32B). The key difference: Impinj Inc is far larger — about 2.4× ADMA Biologics Inc's market cap, and Impinj Inc is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.
| ADMA | PI | |
|---|---|---|
Market Cap | $2.22B | $5.32B |
Sector | Health | Technology |
52-Week High | $20.38 | $241.91 |
52-Week Low | $7.60 | $91.34 |
Enterprise Value | $2.29B | $5.45B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Impinj Inc
Impinj, Inc. is a leading provider of RAIN RFID (radio-frequency identification) solutions. The company's platform includes endpoints (tag chips), connectivity devices (readers and gateways), and software, enabling businesses to wirelessly identify, locate, and authenticate everyday items. Impinj's technology is crucial for applications in retail, supply chain management, healthcare, and logistics, helping businesses to automate inventory, track assets, and improve operational efficiency.
Read more on PI →
